MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • 2019 International Congress

    BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE

    Z. Kosutzka, P. Brandoburova, I. Straka, V. Veronika, P. Valkovic, M. Hajduk (Bratislava, Slovakia)

    Objective: The aim of the current study is to directly compare performance in recognition of facial and bodily emotions. Background: Patients with Parkinson´s disease (PD)  show…
  • 2019 International Congress

    Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

    C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

    Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
  • 2019 International Congress

    Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil

    N. Sousa, A. Neri, I. Brandi, S. Brucki (Salvador, Brazil)

    Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…
  • 2019 International Congress

    Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease

    B. Chase, A. Mertens, J. Santo, K. Markopoulou (Omaha, NE, USA)

    Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • 2019 International Congress

    Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Darbhanga, India)

    Objective: The present study examined the potential neuroprotective and neurotrophic efficacy of GBE against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD…
  • 2019 International Congress

    Modulation of the Startle Response in REM Sleep Behavior Disorder

    M. Puligheddu, M. Figorilli, ML. Fantini, M. Carta, F. Traccis, R. Frau, P. Devoto, D. Pani, M. Bortolato (Salt Lake City, UT, USA)

    Objective: To detect changes in the modulation of the Startle Reflex induced by brainstem circuitry abnormalities both in isolated and PD related Rem Behaviour Disorder…
  • 2019 International Congress

    Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

    N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)

    Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
  • 2019 International Congress

    Puzzle resolution as cognitive test in Parkinson´s disease patients

    C. Borrue-Fernandez, D. Santos-García, J. Pagonabarraga, B. Pascual-Sedano, M. Mata, C. Study Group (Madrid, Spain)

    Objective: To analyze the value of puzzle resolution for cognitive testing in Parkinson´s disease patients. Background: Cognitive decline and dementia are common among Parkinson disease…
  • « Previous Page
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley